issued
on 25 Jun 2024
Last Applicant/ Owned by
40 Erie Street
Cambridge
MA
02139
Serial Number
97830256 filed on 09th Mar 2023
Registration Number
N/A
Correspondent Address
Jonathan M. Gelchinsky
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific research in the nature of conducting clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology Medical treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology Organizing and recruiting patients for clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology
Medical treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology
N/A
N/A
Scientific research in the nature of conducting clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology
N/A
N/A
Organizing and recruiting patients for clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology
N/A
N/A
No 97830256
No Service Mark
No 33485/6220
No
No
No
No
No
No
No
No
01.05.01 -
Sun, rising or setting (partially exposed or partially obstructed)
Status Date | Action Taken |
---|---|
16th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
25th Jun 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
30th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
30th Apr 2024 | PUBLISHED FOR OPPOSITION |
10th Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
22nd Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
23rd Feb 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
23rd Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
23rd Feb 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
23rd Dec 2023 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |